Charles River offers a full range of drug metabolism and pharmacokinetic (DMPK) studies in support of drug candidate selection or regulatory submission. Our skilled in vitro and in vivo ADME scientists, together with our pharmacokineticists, surgeons and bioanalytical chemists, can design and interpret both in vitro and in vivo components of your drug metabolism studies, based on your program goals. Located in Montreal, Canada and Edinburgh, UK, Charles River’s state-of-the-art metabolism and clinical pharmacokinetics laboratories offer fully validated, networked data management systems for radioisotopic, chromatographic and pharmacokinetic evaluations. A comprehensive range of pharmacokinetics study types is available.
drug metabolism & pharmacokinetics (DMPK)